Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Preliminary Study of the Neurological and Neuropsychological Effects of Palynziq-Related Changes in Phenylalanine in Individuals With Phenylketonuria (PKU)

NCT05356377 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT05356377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05356377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Preliminary Study of the Neurological and Neuropsychological Effects of Palynziq-Related Changes in Phenylalanine in Individuals With Phenylketonuria (PKU)
Lead sponsor
University of Missouri-Columbia
Phase
Observational
Overall status
Completed
Start date
May 25, 2022
Completion date
July 1, 2025
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

phenylketonurias